The ECG morphology of ventricular tachyarrhythmias observed in patients with CPVT resembles that of VTs commonly described in digitalis toxicity (which is associated with cellular calcium overload), and in metabolic disturbances as seen in severe HF (which is associated with high adrenergic tone). 3 In conditions of cytoplasmic Ca 2þ overload or enhanced b-adrenergic signalling, cardiac myocytes exhibit greater ectopic activity. It has therefore been suggested that arrhythmias in CPVT are mediated by triggered activity and delayed afterdepolarizations (DADs), which are defined as oscillations in the membrane potential of the cardiac myocyte after repolarization of an action potential has been completed. 1 The most common, autosomal-dominant form of CPVT is caused by genetic mutations in the gene encoding the cardiac ryanodine receptor (RyR2), the principal intracellular Ca 2þ release channel involved in excitation-contraction coupling. 4 Although experimental studies have provided evidence that mutant RyR2 channels can give rise to DADs in isolated cardiomyocytes, 5 the study by Paavola et al. 6 demonstrates DADs in monophasic action potential (MAP) recordings for the first time in CPVT patients with RyR2 mutations.
Clinical evidence for DADs in patients with CPVT
In contrast to conventional electrode catheter recordings, MAP recordings provide precise information not only about the local activation time, but also about the entire repolarization time course. Electrophysiological data for the occurrence of DADs in patients with CPVT have been scarce in the literature, with the exception of a case report by Nakajima et al. 2 In this study of a 14-year-old male with CPVT, endocardial MAP recordings at the inflow of the right ventricle revealed 'humps' following the previous action potential, which is consistent with DADs. The amplitude of these signals increased following the infusion of isoproterenol, and the DADs were frequently followed by ventricular premature beats and bidirectional VT. 2 The studies by Paavola et al. 6 significantly extend these findings by demonstrating the occurrence of DADs in genotyped patients with CPVT. Endocardial MAP recordings were performed in 15 CPVT patients with known RyR2 mutations and 12 age-matched controls. Under baseline conditions, DADs were observed in 20% (three out of 15) of the CPVT patients, whereas no DADs were found in control subjects. Since none of these patients exhibited arrhythmias or symptoms at rest, it is conceivable that DADs by themselves may not be sufficient to initiate triggered arrhythmias. Indeed, the amplitude of a DAD needs to be of sufficient amplitude before it can trigger an action potential. Moreover, premature ventricular complexes can only lead to arrhythmias in the presence of a susceptible substrate (e.g. a ventricle that is partially refractory, or has conduction abnormalities). 7 Following low dose epinephrine infusion, 27% (four out of 15) of the CPVT patients showed DADs. Epinephrine increased the amplitude and the slope of DADs, and occasionally led to premature ventricular beats. 6 These findings indicate that larger DADs evoked by epinephrine stimulation are more capable of triggering action potentials and premature ventricular beats. On the other hand, it is surprising that not more patients exhibited DADs in this study, considering that most patients (80%; 12 out of 15) of this cohort had experienced exercise-related syncope or cardiac arrest. One possible explanation is that DADs were not detected as MAP recordings were only obtained from one site (i.e. the right ventricular septum). Another possibility is that the epinephrine dose administered during electrophysiological
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society Cardiology. studies was lower than the catecholamine levels released during stress or physical exercise. The average heart rate in patients with CPVT increased from 72 beats per minute (b.p.m.) to 87 b.p.m., which is well below the average threshold heart rate at which ventricular premature beats occurred during exercise testing (130 b.p.m.). Nevertheless, the demonstration of DADs in patients with RyR2 is an important observation that facilitates the interpretation of experimental studies in this field of research.
Ionic mechanisms underlying DADs in CPVT
DADs occur after the repolarization of the preceding action potential has been completed, and are caused by aberrant release of Ca 2þ from the sarcoplasmic reticulum (SR) intracellular Ca 2þ stores. 8 Spontaneous SR Ca 2þ release events that cause DADs in single myocytes often begin in a small region of the cell. The locally elevated Ca 2þ then diffuses to adjacent calcium-release units where it activates other Ca 2þ release channels, which induces Ca 2þ release that propagates throughout the cell (Figure 1) . The resulting elevation of cytosolic Ca 2þ concentrations may activate the Na þ /Ca 2þ exchanger, which leads to extrusion of Ca 2þ from the cell in exchange for an influx of Na þ into the cell. 9 Triggered activity arises when the depolarization threshold is reached, resulting in a ventricular premature complex.
Strong evidence for a causal link between defective RyR2 gating and DADs was obtained in cardiomyocytes isolated from knockin mice, heterozygous for the CPVT-associated RyR2 mutations R4496C or R176Q. 5, 10 Action potential recordings from R4496Cþ/2 mice revealed DADs that appeared more frequently following isoproterenol stimulation. 5 Measurements of intracellular Ca 2þ concentrations demonstrated spontaneous SR Ca 2þ release events in myocytes isolated from R176Qþ/2 mice. 10 Although these Ca 2þ release events were observed under baseline conditions, the frequency and amplitude of these DAD triggers were enhanced following isoproterenol stimulation. Thus, studies in both patients and mice with inherited RyR2 mutations have clearly demonstrated that abnormal intracellular Ca 2þ release through mutant RyR2 channels can initiate DADs, which could trigger lethal ventricular arrhythmias.
RyR2 defects associated with CPVT-linked mutations
Ryanodine receptors are ion channels located on the SR membrane, responsible for Ca 2þ release from the SR. Channel complexes are comprised of four pore-forming RyR2 subunits, each of which is associated with various proteins that modulate channel function. 11 For example, activation of b-adrenergic receptors by catecholamines results in the activation of cAMP-dependent protein kinase A (PKA) bound to the RyR2 macromolecular complex. Activated PKA phosphorylates serine 2808 on RyR2, which decreases the binding affinity of the channel-stabilizing subunit calstabin2 (also known as FKBP12.6). This sequence of signalling events renders RyR2 more sensitive to Ca 2þ -dependent activation, enabling enhanced intracellular Ca 2þ release during stress or exercise. 11 Paavola et al. 6 expressed mutant RyR2 channels in HEK293 cells and recorded calcium release events using confocal microscopy to study the mechanisms by which genetic mutations cause enhanced SR Ca 2þ release. HEK293 cells expressing CPVT-mutant RyR2 channels showed spontaneous Ca 2þ release events at lower concentrations of cAMP than cells transfected with wild-type RyR2 channels. These findings are consistent with the occurrence of DADs in patients carrying the same RyR2 mutations. It is very likely that the DADs are initiated by diastolic SR Ca 2þ 'leakage' through CPVT-mutant RyR2 channels. The single channel properties of P2328S, Q4201R, and V4653F mutant RyR2 channels have been previously characterized using the planar lipid bilayer system. 12 PKA-phosphorylated CPVT-mutant channels exhibited abnormally high open probabilities at low cytosolic Ca 2þ concentrations, which are in agreement with the increased likelihood of DADs observed in HEK293 cells expressing these mutant RyR2 channels.
Several molecular mechanisms have been proposed for the abnormal diastolic activity of mutant RyR2 channels. Jiang et al. 13 have suggested that mutant RyR2 channels may be more sensitive to luminal (SR) Ca 2þ activation by a mechanisms referred to as 'store-overload induced Ca 2þ release'. Wehrens et al.
14 have shown that CPVT-associated RyR2 mutations reduce the affinity for the channelstabilizing subunit calstabin2 (FKBP12.6), a phenomenon that was also observed for the P2328S, Q4201R, and V4653F mutant channels. 12 In addition, it has been proposed that CPVT mutations alter interactions between domains within the channel complex, leading to 'domain unzipping' and a reduced threshold to diastolic SR Ca 2þ leakage. 15 The finding that DADs also occur under baseline conditions in patients with CPVT argues in favour of an intrinsic RyR2 channel defect (i.e. an increased sensitivity to activation by Ca 2þ or stimulation by cAMP), and appears to be inconsistent with the store-overload hypothesis (as SR overload is not likely to occur under resting conditions). Additional studies in patients with CPVT and in cardiomyocytes expressing CPVT-mutant RyR2 channels are warranted to further explore the triggers of DADs and mechanisms underlying SR Ca 2þ leak through mutant RyR2 channels.
